RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsNerio’s preclinical small molecule tyrosine phosphatases PTPN2/N1 inhibitors are speculated to improve immune function and sensitize tumors to pro-inflammatory signals, promoting robust anti-tumor activity.